Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 47Breast Neoplasms 6Leiomyoma 5Neoplasms 4Adenocarcinoma 2Uterine Neoplasms 1Urogenital Neoplasms 1Prostatic Diseases 1Premenopausal Breast Cancer 1Polycystic Ovary Syndrome 1Neoplasms, Glandular and Epithelial 1Neoplasm Metastasis 1Myofibroma 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lower Urinary Tract Symptoms 1Infertility 1Hodgkin Disease 1Hereditary Sensory and Autonomic Neuropathies 1Genital Neoplasms, Male 1Carcinoma 1Breast Neoplasms, Male 1Advanced Prostate Cancer 1Advanced Prostate Adenocarcinoma 1

Interventions

Goserelin 2enzalutamide 1bicalutamide 1acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1Leuprolide 1Gonadotropin-Releasing Hormone 1Abiraterone Acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Advanced Prostate Cancer × Leuprolide × Clear all
NCT06490328 2024-07-08

Efficacy and Safety of DKF-MA102 in Patients With Prostate Cancer

Dongkook Pharmaceutical Co., Ltd.

Phase 3 Recruiting
154 enrolled
Genitourinary

Advanced Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡